Improved heart preservation with UW preservation solution. 1988

D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
Division of Thoracic and Cardiovascular Surgery, University of Wisconsin Hospital and Clinics, Madison.

Despite the good clinical results obtained with the current heart preservation techniques, these methods need to be improved. The UW solution has provided excellent preservation for the pancreas, kidney, and liver after extended cold ischemic storage times. We have tested the ability of the UW solution to store hearts for 5 and 12 hours and compared the results with those obtained from hearts preserved by either Stanford or modified Collins' solutions. Three groups of five canine hearts each underwent 5 hours, and three groups of five canine hearts underwent 12 hours of ischemia at 4 degrees C. Then the hearts were reperfused in an isolated working canine heart preparation. Those hearts preserved for 5 hours had nearly normal ventricular function and adenosine triphosphate contents and were able to maintain normal tissue electrolyte concentration and water contents. After 12 hours of storage time only adenosine triphosphate contents were similar among the groups. Hearts preserved with the UW solution rapidly recovered, reaching nearly normal left ventricular function by 60 minutes of reperfusion; hearts preserved by the modified Collins' solution recovered more slowly, but function was good after 120 minutes of reperfusion. Hearts preserved by the Stanford solution never attained adequate function. The three groups of hearts preserved for 12 hours did not differ in their ability to utilize lactate or in their rates of oxygen utilization. Tissue water and sodium contents were considerably lower in the hearts preserved with the UW solution after 150 minutes of reperfusion compared with hearts stored in the modified Collins' or Stanford solutions. Hearts stored 12 hours in the UW solution under cold ischemic conditions recovered left ventricular function rapidly after reperfusion with normal blood, utilized lactate and oxygen at normal rates, and were able to regulate tissue water and sodium contents to nearly normal levels. Because of the superior preservation obtained by the UW solution, the solution deserves further evaluation for possible future use in clinical heart transplant programs.

UI MeSH Term Description Entries
D006982 Hypertonic Solutions Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid. Hypertonic Solution,Solution, Hypertonic,Solutions, Hypertonic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009926 Organ Preservation The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Organ Preservations,Preservation, Organ,Preservations, Organ
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D011189 Potassium Chloride A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. Slow-K,Chloride, Potassium
D011887 Raffinose A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal. Gossypose,Melitose,Melitriose
D002314 Cardioplegic Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. Cardioplegic Solution,Solution, Cardioplegic,Solutions, Cardioplegic
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold

Related Publications

D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
April 1990, Transplantation proceedings,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
October 1989, Transplantation proceedings,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
June 1989, Transplantation,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
October 1989, Transplantation proceedings,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
April 1990, Transplantation proceedings,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
November 1992, Transplantation,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
June 1991, The Journal of surgical research,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
February 1989, Transplantation proceedings,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
December 1997, Transplantation proceedings,
D K Swanson, and I Pasaoglu, and H A Berkoff, and J A Southard, and J O Hegge
January 1992, Transplant international : official journal of the European Society for Organ Transplantation,
Copied contents to your clipboard!